Baxter subsidiary sues B. Braun over blood filtration system

January 18, 2018 By Sarah Faulkner Leave a Comment

Baxter (NYSE:BAX) and its subsidiary Gambro filed a patent infringement lawsuit against B. Braun last week, claiming that the German medical device maker’s Omni blood purification system infringes on seven of the patents covering Baxter’s Prismaflex system. The devices are used to treat patients who have acute kidney injuries and need help filtering out the waste […]

China halts anti-dumping probe into EU, Japan dialysis kit makers

December 17, 2014 By MassDevice Leave a Comment

NxStage, Gambro bury the hatchet, renew supply deal

January 7, 2014 By Brad Perriello Leave a Comment

Baxter and Gambro seal the deal on $3.9B acquisition

September 9, 2013 By Arezu Sarvestani Leave a Comment

Baxter and Gambro officially seal the deal on $3.9B merger

Baxter (NYSE:BAX) announced late last week that it finally sealed the deal on its $3.9 billion acquisition of Swedish dialysis giant Gambro AB, closing the books on a deal months in the making.

Aussie regulators approve Baxter’s $4B Gambro merger

September 5, 2013 By Arezu Sarvestani Leave a Comment

Baxter appeases EU regulators in $4B Gambro buyout

August 22, 2013 By Sony Salzman Leave a Comment

Baxter appeases EU regulators, closes $4B Gambro buyout

After months of negotiations with EuroZone regulators, Baxter‘s (NYSE:BAX) nearly $4 billion buyout of Swedish dialysis maker Gambro AB can go forward now that Baxter agreed to sell off its renal replacement therapy division to ease anti-trust concerns.

Sources say Baxter’s near an agreement with EU regulators in $4B Gambro merger

July 11, 2013 By Sony Salzman Leave a Comment

Healthcare giant Baxter (NYSE:BAX) may be on the verge of closing its $4 billion buyout of Swedish dialysis devices maker Gambro AB after offering to divest some of its assets in order to appease European regulators, according to anonymous sources cited by Reuters.

Baxter aims to soothe E.U. antitrust concerns over $4B Gambro merger

July 5, 2013 By Sony Salzman Leave a Comment

Baxter (NYSE:BAX) offered European regulators concessions to lessen antitrust concerns over the $4 billion (26.5 billion SEK) acquisition of Swedish dialysis giant Gambro.

Greatbatch raises 2013 guidance on restructuring efforts | Wall Street Beat

June 6, 2013 By Arezu Sarvestani Leave a Comment

Texas medical device maker Greatbatch (NYSE:GB) raised its 2013 per-share earnings guidance as it announced new efforts to reorganize some of its business practices and reduce costs as it shifts from a components and sub-assemblies company to a developer of full medical devices.

Medtronic closes strategic investment in LifeTech | Wall Street Beat

January 30, 2013 By MassDevice staff Leave a Comment

Medtronic (NYSE:MDT) said it’s closed a $66 million investment in Chinese medical device company LifeTech Scientific (HK:8122).

Rumors of Baxter’s $4B Gambro buyout prove true

December 4, 2012 By MassDevice staff Leave a Comment

Rumors circulating late last month proved true with Baxter (NYSE:BAX) this week announced that it had signed a $4 billion (26.5 billion SEK) merger agreement with Swedish dialysis giant Gambro.